Search results for " type 2"

showing 10 items of 761 documents

Red Cell Membrane Protein Lateral Mobility in Diabetes Mellitus

1992

In a group of 24 diabetics subdivided for type, we evaluated the red cell membrane protein lateral mobility marking intact red cells with pyrene-3-maleimide (3-PM) and calculating the dimer to monomer fluorescence intensity ratio (Iex/Im). The same fluorescent parameter was determined in a group of 13 normal controls. From the obtained data, it is evident that the red cell membrane protein lateral mobility clearly discriminates normals from diabetics of type 1 and 2. In normals and in diabetics of type 1 and 2 no relationship is present between this fluorescent determinant and the glycometabolic parameters (FBGL and HbA1c); considering all the diabetics, a negative relationship is evident b…

AdultBlood GlucoseMalemedicine.medical_specialtyAdolescentEndocrinology Diabetes and MetabolismDimerClinical BiochemistryBiologyBiochemistryBlood cellchemistry.chemical_compoundEndocrinologyInternal medicineDiabetes mellitusDiabetes MellitusmedicineHumansChildAgedGlycated HemoglobinErythrocyte MembraneBiochemistry (medical)Membrane ProteinsGeneral MedicineMiddle Agedmedicine.diseaseFluorescenceRed cell membraneFluorescence intensityRed blood cellDiabetes Mellitus Type 1Endocrinologymedicine.anatomical_structureDiabetes Mellitus Type 2Membrane proteinchemistryFemaleHormone and Metabolic Research
researchProduct

Are general practitioners characteristics associated with the quality of type 2 diabetes care in general practice? Results from the Norwegian ROSA4 s…

2018

Abstract Objective: To explore the associations between general practitioners (GPs) characteristics such as gender, specialist status, country of birth and country of graduation and the quality of care for patients with type 2 diabetes (T2DM). Design: Cross-sectional survey. Setting and subjects: The 277 GPs provided care for 10082 patients with T2DM in Norway in 2014. The GPs characteristics were self-reported: 55% were male, 68% were specialists in General Practice, 82% born in Norway and 87% had graduated in Western Europe. Of patients, 81% were born in Norway and 8% in South Asia. Data regarding diabetes care were obtained from electronic medical records and manually verified. Main outc…

AdultBlood GlucoseMalemedicine.medical_specialtyAsiaCross-sectional studyGeneral PracticeEthnic groupBlood PressureNorwegian030204 cardiovascular system & hematology03 medical and health sciencesspecializationfamily medicine0302 clinical medicineGeneral Practitionersquality of careEthnicitymedicinegenderHumans030212 general & internal medicinePractice Patterns Physicians'Screening proceduresQuality of Health CareGlycated HemoglobinNorwaybusiness.industrylcsh:Public aspects of medicineMedical recordPublic Health Environmental and Occupational Healthlcsh:RA1-1270Type 2 diabetesMiddle Agedlanguage.human_languagePeer reviewEuropeCross-Sectional StudiesDiabetes Mellitus Type 2Family medicinegeneral practitionerlanguageGlobal Positioning SystemFemaleGuideline AdherencebusinessResearch ArticleGraduation
researchProduct

Once-Daily Liraglutide Versus Lixisenatide as Add-on to Metformin in Type 2 Diabetes: A 26-Week Randomized Controlled Clinical Trial

2016

OBJECTIVE To compare the efficacy and safety of liraglutide versus lixisenatide as add-on to metformin in patients with type 2 diabetes not achieving adequate glycemic control on metformin alone. RESEARCH DESIGN AND METHODS In this 26-week, randomized, parallel-group, open-label trial, 404 patients were randomized 1:1 to liraglutide 1.8 mg or lixisenatide 20 µg as add-on to metformin. Liraglutide was administered once daily at any time of the day. Lixisenatide was administered once daily within 1 h prior to the morning or evening meal. RESULTS At week 26, liraglutide reduced HbA1c (primary end point) more than lixisenatide (estimated treatment difference −0.62% [95% CI −0.8; −0.4]; P &…

AdultBlood GlucoseMalemedicine.medical_specialtyEndocrinology Diabetes and Metabolism030209 endocrinology & metabolismType 2 diabetes030204 cardiovascular system & hematologyHypoglycemiaDrug Administration Schedulelaw.inventionYoung Adult03 medical and health sciencesLixisenatidechemistry.chemical_compound0302 clinical medicineRandomized controlled triallawInternal medicineInternal MedicinemedicineClinical endpointHumansHypoglycemic AgentsAgedGlycemicAged 80 and overGlycated HemoglobinAdvanced and Specialized NursingLiraglutidebusiness.industryBody WeightLiraglutideMiddle AgedPostprandial Periodmedicine.diseaseHypoglycemiaMetforminMetforminTreatment OutcomeEndocrinologyDiabetes Mellitus Type 2chemistryDrug Therapy CombinationFemalePeptidesbusinessmedicine.drugDiabetes Care
researchProduct

Circulating Apelin is increased in patients with type 1 or type 2 diabetes and is associated with better glycaemic control

2013

SummaryContext Apelin is an adipokine expressed in several tissues and it appears to be involved in energy metabolism. Objective The aim of this study was to determine serum apelin levels in a large cohort of patients with type 1 and type 2 diabetes and control subjects and to correlate the results with glycaemic control. Design and Participants One hundred and thirty patients with type 1 diabetes, 98 patients with type 2 diabetes and 162 controls were enrolled in the study. Apelin levels were measured by enzyme-linked immunosorbent assay. Results Serum apelin levels were significantly higher in type 1 and type 2 diabetic patients than in controls (P < 0·0001). Serum apelin levels were high…

AdultBlood GlucoseMalemedicine.medical_specialtyEndocrinology Diabetes and MetabolismAdipokineType 2 diabetesEndocrinologyInsulin resistanceInternal medicineDiabetes mellitusmedicineHumansAgedGlycated HemoglobinType 1 diabetesbusiness.industryCase-control studyMiddle Agedmedicine.diseaseObesityUp-RegulationApelinDiabetes Mellitus Type 1EndocrinologyDiabetes Mellitus Type 2Case-Control StudiesApelinIntercellular Signaling Peptides and ProteinsFemaleInsulin ResistancebusinessBiomarkersClinical Endocrinology
researchProduct

Bioelectrical characteristics of type 1 and type 2 diabetic subjects with reference to body water compartments.

1998

Since bioelectrical characteristics correspond well to body water compartments, this study investigated bioelectrical differences between type 1 and type 2 diabetic subjects that could reflect differences in body water compartments. We investigated cross-sectionally 612 adult subjects, classified into 10 groups according to sex and disease (control, obese normal glucose tolerant, non-obese type 2 diabetes, obese type 2 diabetes, type 1 diabetes). Resistance (R), reactance (Xc) and phase angle (PA) were measured (800 microA - 50 kHz alternating current). The bioelectrical vector was obtained by plotting R and Xc normalized for height (ht), it is easily identified on the basis of the length (…

AdultBlood GlucoseMalemedicine.medical_specialtyEndocrinology Diabetes and MetabolismBody waterType 2 diabetesEndocrinologyBody WaterInternal medicineDiabetes mellitusInternal MedicineElectric ImpedanceMedicineHumansAgedType 1 diabetesbusiness.industryPhase angleGeneral MedicineBody Fluid CompartmentsFastingAnthropometryMiddle Agedmedicine.diseaseObesityEndocrinologyCross-Sectional StudiesDiabetes Mellitus Type 1Diabetes Mellitus Type 2FemaleAnalysis of variancebusinessActa diabetologica
researchProduct

The relationship between type 2 diabetes family history, body composition and blood basal glycemia in sedentary people.

2013

The aim of this study was to verify whether there is a positive correlation between family history to type 2 diabetes mellitus and body mass and composition, and alterations in blood basal glycaemia levels in sedentary male and female. Anthropometric variables, blood parameters, body composition and body surface area were evaluated on 183 male and 237 female sedentary individuals. Participants were classified into two groups: FH(+) (family history positive) and FH(-) (familiar history negative) according to their medical history. The FH(+) group showed higher values of body mass and body surface area than FH(-) group. These differences were statistically significant (p < 0.05) for the femal…

AdultBlood GlucoseMalemedicine.medical_specialtyEndocrinology Diabetes and MetabolismPhysical exerciseType 2 diabetesBiologyYoung AdultEndocrinologySex Factorstype 2 diabetes exercise healthRisk FactorsInternal medicineDiabetes mellitusSurveys and QuestionnairesInternal MedicinemedicineHumansFamily historyRisk factorBody surface areaFamily HealthType 2 Diabetes MellitusGeneral MedicineAnthropometrymedicine.diseaseEndocrinologyDiabetes Mellitus Type 2Body CompositionFemaleSedentary BehaviorActa diabetologica
researchProduct

How often patients on insulin therapy measure postprandial glycemia and modify insulin doses accordingly? From an on-line survey in insulin-treated d…

2019

Abstract Introduction Controlling postprandial glycemia (PPG) is important to achieve optimal glycemic control, but few studies have evaluated how often is measured and evaluated. Objectives To evaluate how often patients on insulin therapy measure PPG and modify insulin doses accordantly. As secondary objectives, we evaluated the factors conditioning elevated PPG and associated issues. Material and methods Cross-sectional observational study based on a web-based survey from an unselected sample of adult insulin-treated patients. A p-value of  Results 1251 patients (68% women, 38.9 ± 13 years [mean ± SD], body mass index (BMI) 24.2 ± 4.2 kg/m2, diabetes duration 17.4 ± 12.8 years, insulin d…

AdultBlood GlucoseMalemedicine.medical_specialtyEndocrinology Diabetes and Metabolismmedicine.medical_treatment030209 endocrinology & metabolismDisease03 medical and health sciences0302 clinical medicineEndocrinologySurveys and QuestionnairesDiabetes mellitusInternal medicineInternal MedicineHumansHypoglycemic AgentsInsulinMedicine030212 general & internal medicineGlycemicGlycated HemoglobinBlood glucose monitoringmedicine.diagnostic_testbusiness.industryBlood Glucose Self-MonitoringInsulinGeneral MedicineMiddle AgedPostprandial Periodmedicine.diseaseCross-Sectional StudiesDiabetes Mellitus Type 1PostprandialDiabetes Mellitus Type 2SpainHyperglycemiaFemaleObservational studysense organsbusinessBody mass indexDiabetes Research and Clinical Practice
researchProduct

Levels of C3 in patients with severe, morbid and extreme obesity: its relationship to insulin resistance and different cardiovascular risk factors.

2007

Increased C3 has been related to body mass index (BMI) and insulin resistance, although there are not sufficient studies in subjects with morbid obesity. The purpose of this study was to evaluate the levels of C3 as a function of the BMI in subjects of both sexes, with severe, morbid and extreme obesity, and their possible relationship to insulin resistance or associated diseases such as diabetes, hypertension and dyslipidemia.The study included a total of 316 patients (110 men and 206 women) with severe obesity (17.1%), morbid obesity (54.4%) and extreme obesity (28.4%), with an average BMI of 46.70+/-7.37 kg/m2.The glucose and insulin levels were determined baseline, and 2 h after a 75 g …

AdultBlood GlucoseMalemedicine.medical_specialtyEndocrinology Diabetes and Metabolismmedicine.medical_treatmentMedicine (miscellaneous)Blood Pressuremacromolecular substancesBody Mass IndexInsulin resistanceRisk FactorsInternal medicineEpidemiologymedicineHyperinsulinemiaHumansInsulinObesityRisk factorPancreatic hormoneDyslipidemiasNutrition and DieteticsVascular diseasebusiness.industryInsulinComplement C3medicine.diseaseObesity MorbidEndocrinologyDiabetes Mellitus Type 2Cardiovascular DiseasesHypertensionFemaleInsulin ResistancebusinessHyperinsulinismInternational journal of obesity (2005)
researchProduct

Influence of glucose control and improvement of insulin resistance on microvascular blood flow and endothelial function in patients with diabetes mel…

2005

The study was performed to investigate the effect of improving metabolic control with pioglitazone in comparison to glimepiride on microvascular function in patients with diabetes mellitus type 2.A total of 179 patients were recruited and randomly assigned to one treatment group. Metabolic control (HbA1c), insulin resistance (HOMA index), and microvascular function (laser Doppler fluxmetry) were observed at baseline and after 3 and 6 months.HbA1c improved in both treatment arms (pioglitazone: 7.52 +/- 0.85% to 6.71 +/- 0.89%, p.0001; glimepiride: 7.44 +/- 0.89% to 6.83 +/- 0.85%, p.0001). Insulin-resistance decreased significantly in the pioglitazone group (6.15 +/- 4.05 to 3.85 +/- 1.92, p…

AdultBlood GlucoseMalemedicine.medical_specialtyEndotheliumPhysiologyArbitrary unitInsulin resistancePhysiology (medical)Diabetes mellitusInternal medicinemedicineHumansHypoglycemic AgentsMolecular BiologyAgedPioglitazonebusiness.industryMicrocirculationGlucose clamp techniqueMiddle Agedmedicine.diseaseGlimepirideEndocrinologymedicine.anatomical_structureSulfonylurea CompoundsDiabetes Mellitus Type 2Metabolic control analysisGlucose Clamp TechniqueFemaleThiazolidinedionesEndothelium VascularInsulin ResistanceCardiology and Cardiovascular MedicinebusinessPioglitazoneBlood Flow Velocitymedicine.drugMicrocirculation (New York, N.Y. : 1994)
researchProduct

Glycated serum proteins and glucose tolerance

1988

Glycated serum proteins (GSP), stable glycated hemoglobin (HbA1c) together with some metabolic parameters were evaluated in 120 subjects, 30 with normal glucose tolerance (NGT), 30 with impaired glucose tolerance (IGT), 30 with non-insulin-dependent diabetes mellitus (NIDD), and 30 with insulin-dependent diabetes mellitus (IDD). GSP levels were significantly higher in IGT, NIDD and IDD than in NGT. HbA1c levels were not significantly higher in IGT in comparison with NGT, but were significantly higher in NIDD and in IDD than in NGT and IGT. GSP correlated better than HbA1c with all metabolic parameters considered. Taking into account the distribution of the values, GSP showed a smaller overl…

AdultBlood GlucoseMalemedicine.medical_specialtyGlycosylationendocrine system diseasesEndocrinology Diabetes and MetabolismImpaired glucose toleranceHba1c levelchemistry.chemical_compoundEndocrinologystomatognathic systemReference ValuesInternal medicineDiabetes mellitusInternal MedicinemedicineHumansTriglyceridesGlycated HemoglobinGlucose tolerance testmedicine.diagnostic_testbusiness.industryCholesterolnutritional and metabolic diseasesBlood ProteinsGeneral MedicineGlucose Tolerance TestMiddle Agedmedicine.diseaseBlood proteinsCholesterolDiabetes Mellitus Type 1EndocrinologyDiabetes Mellitus Type 2chemistryHyperglycemiaMetabolic control analysisFemaleGlycated hemoglobinbusinesshormones hormone substitutes and hormone antagonistsActa Diabetologica Latina
researchProduct